Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune gastritis is a common cause of iron deficiency and should be included in diagnostic guidelines.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Trichothiodystrophy is a condition with brittle hair and various physical and mental issues due to low sulfur in proteins.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Belatacept may be a promising treatment for alopecia areata.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

TrichoScan offers a painless way to analyze and manage hair loss.

HLA can be linked to autoimmune hepatitis.

Trichoscopy is better than trichogram for diagnosing early female hair loss.

A unique hair tumor with a rippled pattern was identified, showing incomplete differentiation and unusual cell arrangements.

Adalimumab may cause severe hair loss in some patients.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Immunoadsorption successfully treated a man's resistant polymyositis.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.